GURGAON, India--(BUSINESS WIRE)--Ranbaxy Laboratories Limited (Ranbaxy) today announced the launch of Letrozole Tablets 2.5 mg in UK, Romania and France, on Day-1. Letrozole is the bio equivalent of Femara, the innovator product of Novartis, that has a market size of USD 58 Mn in UK (Source: IMS 2010), USD 95 Mn in France (Source: GERS May 2011) and USD 5.5 Mn in Romania (Source: Cegedim2010).
